Literature DB >> 22523209

CDX2 expression in columnar cell variant of papillary thyroid carcinoma.

Miriam L Enriquez1, Zubair W Baloch, Kathleen T Montone, Paul J Zhang, Virginia A LiVolsi.   

Abstract

The columnar cell variant of papillary thyroid carcinoma (CCV-PTC) is a rare subtype of PTC that exhibits morphologic features often described as reminiscent of secretory endometrium or colonic adenomas/adenocarcinomas. CDX2, a nuclear transcription factor, is important for intestinal development. It is normally expressed in intestinal epithelium and is also detected in adenoma and adenocarcinomas of the gastrointestinal tract; however, it has also been reported in tumors of other sites with intestinal-type morphologic features. We evaluated CDX2 expression in CCV-PTC and in a thyroid tissue microarray composed of various benign and malignant thyroid lesions. CDX2 expression was identified in 6 (55%) of 11 cases of CCV-PTC, but not in any other benign and malignant thyroid lesions. We conclude that CDX2 is selectively expressed in CCV-PTC and can be used in distinguishing it from other variants of PTC with overlapping morphologic features.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523209     DOI: 10.1309/AJCPXE3PUBWVZCGZ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

Review 1.  Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma.

Authors:  Tyler Janovitz; Justine A Barletta
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

2.  Images in endocrine pathology: similar, but not the same!

Authors:  Massimo Bongiovanni; Simonetta Piana; Stefano Crippa; Moira Ragazzi; Luca Giovanella
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

Review 3.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

4.  Pathology of Struma Ovarii: A Report of 96 Cases.

Authors:  Shuanzeng Wei; Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 5.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

Review 6.  Aggressive variants of follicular cell-derived thyroid carcinoma: an overview.

Authors:  Cristina Pizzimenti; Vincenzo Fiorentino; Antonio Ieni; Maurizio Martini; Giovanni Tuccari; Maria Lentini; Guido Fadda
Journal:  Endocrine       Date:  2022-07-21       Impact factor: 3.925

7.  STK11 Mutation Identified in Thyroid Carcinoma.

Authors:  Shuanzeng Wei; Virginia A LiVolsi; Marcia S Brose; Kathleen T Montone; Jennifer J D Morrissette; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

8.  Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.

Authors:  Matthew P Tilson; Gary L Gallia; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2013-07-12

Review 9.  Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.

Authors:  Andrés Coca-Pelaz; Jatin P Shah; Juan C Hernandez-Prera; Ronald A Ghossein; Juan P Rodrigo; Dana M Hartl; Kerry D Olsen; Ashok R Shaha; Mark Zafereo; Carlos Suarez; Iain J Nixon; Gregory W Randolph; Antti A Mäkitie; Luiz P Kowalski; Vincent Vander Poorten; Alvaro Sanabria; Orlando Guntinas-Lichius; Ricard Simo; Peter Zbären; Peter Angelos; Avi Khafif; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2020-06-01       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.